• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】28994

【品名】7-amino[1,8]naphthyridin-2-ol

【CA登记号】

【 分 子 式 】C8H7N3O

【 分 子 量 】161.1632

【元素组成】C 59.62% H 4.38% N 26.07% O 9.93%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(II)

The cyclization of 5,6-dihydro-1,4-dithiine-2,3-dicarboxylic acid anhydride (I) with 2-amino-7-hydroxy-1,8-naphthyridine (II) by means of acetic acid in refluxing diphenyl-diphenyl ether gives 6-(7-hydroxy-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-1,4-dithiino[2,3-c]pyrrole-5,7-dione (III), which is treated with POCl3 in hot DMF to yield 6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-1,4-dithiino[2,3-c]pyrrole-5,7-dione (IV). The reduction of (IV) with NaBH4 in methanol affords 6-(7-chloro-1,8-naphthyridin-2-yl)-5-hydroxy-2,3,6,7-tetrahydro-1,4-dithiino[2,3-c]pyrrol-7-one (V), which is finally condensed with 1-chlorocarbonyl-4-methylpiperazine (VI) by means of NaH in DMF.

1 Jeanmart, C.; Leger, A.; Messer, M.N. (Aventis Pharma SA); 1,4-Dithiimo[2,3-c]pyrrole derivatives. CA 989841; DE 2360362; FR 2208651; FR 2209129; FR 2258182; GB 1397060; JP 7493392; NL 7316162; US 3948917; US 3966931; ZA 7309139 .
2 Castaner, J.; Serradell, M.N.; Souto, M.E.; Suriclone. Drugs Fut 1984, 9, 3, 206.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30369 2,3-dihydro[1,4]dithiino[2,3-c]furan-5,7-dione C6H4O3S2 详情 详情
(II) 28994 7-amino[1,8]naphthyridin-2-ol C8H7N3O 详情 详情
(III) 28996 6-(7-hydroxy[1,8]naphthyridin-2-yl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione C14H9N3O3S2 详情 详情
(IV) 28997 6-(7-chloro[1,8]naphthyridin-2-yl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione C14H8ClN3O2S2 详情 详情
(V) 28998 6-(7-chloro[1,8]naphthyridin-2-yl)-7-hydroxy-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-one C14H10ClN3O2S2 详情 详情
(VI) 30370 4-methyl-1-piperazinecarbonyl chloride C6H11ClN2O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The condensation of 2-amino-7-hydroxy-1,8-naphthyridine (I) with 5,6-dihydro-1,7-dithiin-2,3-dicarboxylic acid anhydride (II) in biphenyl-diphenyl ether at 230 C gives 5,7-dioxo-8-(7-hydroxy-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-5H-1,4-dithiino[2,3-c]pyrrole (III), which by reaction with POCl3 at 100 C is converted to the corresponding 7-chloro derivative (IV). Partial reduction of (IV) with KBH4 in methanol yields 6-(7-chloro-1,8-naphthyridin 2-yl)-5-hydroxy-7-oxo-2,3,6,7-tetrahydro-5H-1,4-dithiino[2,3-c]pyrrole (V), which is condensed with 4-chlorocarbonyl-1-(tert-butoxycarbonyl)piperazin (VI) by means of NaH in DMF affording 5-[(4-tert-butoxycarbonylpiperazin-1-yl)carbonyloxy]-6-(7-chloro-1,8-naphthyndin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5H-1,4-dithiino[2,3-c]pyrrole (VII) Deprotection of (VII) by means of trifluoroacetic acid gives 6-(7-chloro-1,8-naphthyridin-2-yl)-7-oxo-5-[(piperazin-1-yl)carbonyloxy]-2,3,6,7-tetrahydro-5H-1,4-dithino[2,3-c]pyrrole (VIII), which is finally acetylated with propionic acid (IX) by means of dicyclohexylcarbodiimide in methylene chloride. The piperazine derivative (VI) is prepared as follows: The condensation of piperazine (X) with tert-butyl azidoformate (XI) in aqueous HCl gives 1-(tert-butoxycarbonyl)piperazine (XII), which is then condensed with phosgene in anhydrous toluene.

1 Cotrel, C.; Crisan, C.; Jeanmart, C.; Messer, M.N. (Aventis Pharma SA); Heterocyclic compounds. BE 0835325; DE 2550111; FR 2313060; FR 2322600; FR 2322601; FR 2322602; GB 1468497; JP 7670776; JP 7733685; JP 7998790; JP 8040671; JP 8051087; US 4220646 .
2 Serradell, M.N.; Castaner, J.; Suproclone. Drugs Fut 1985, 10, 1, 45.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28994 7-amino[1,8]naphthyridin-2-ol C8H7N3O 详情 详情
(II) 28995 2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione C6H5NO2S2 详情 详情
(III) 28996 6-(7-hydroxy[1,8]naphthyridin-2-yl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione C14H9N3O3S2 详情 详情
(IV) 28997 6-(7-chloro[1,8]naphthyridin-2-yl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione C14H8ClN3O2S2 详情 详情
(V) 28998 6-(7-chloro[1,8]naphthyridin-2-yl)-7-hydroxy-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-one C14H10ClN3O2S2 详情 详情
(VI) 28999 tert-butyl 4-(chlorocarbonyl)-1-piperazinecarboxylate C10H17ClN2O3 详情 详情
(VII) 29000 1-(tert-butyl) 4-[6-(7-chloro[1,8]naphthyridin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-yl] 1,4-piperazinedicarboxylate C24H26ClN5O5S2 详情 详情
(VIII) 29001 6-(7-chloro[1,8]naphthyridin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]dithiino[2,3-c]pyrrol-5-yl 1-piperazinecarboxylate C19H18ClN5O3S2 详情 详情
(IX) 20178 propionic acid 79-09-4 C3H6O2 详情 详情
(X) 10355 Diethylenediamine; Piperazine 110-85-0 C4H10N2 详情 详情
(XI) 29002 2-[(azidocarbonyl)oxy]-2-methylpropane C5H9N3O2 详情 详情
(XII) 13225 N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate 143238-38-4 C9H18N2O2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

Condensation of 7-hydroxy-1,8-naphthyridin-2-amine (I) with phthalic anhydride (II) in refluxing acetic acid gives N-(7-hydroxy-1,8-naphthyridin-2-yl)phthalimide (III), which is treated with refluxing POCl3 to yield the 7-chloro derivative (IV). Reduction of compound (IV) with KBH4 in dioxane affords 2-(7-chloro-1,8-naphthyridin-2-yl)-3-hydroxyisoindolin-1-one (V), which is condensed with 5-methyl-2-hexanone (VI) by means of NaH in DMF to give (±)-2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one (VII) (racemic pagoclone). The treatment of (VII) with NaOH in dioxane/water yields the racemic benzoic acid (VIII). Optical resolution of racemic (VIII) by means of (+)-ephedrine or cinchonine affords the (+)-isomer (IX), which is finally cyclized to the chiral (+)-indolinone derivative pagoclone by means of SOCl2 and imidazole in dichloromethane.

1 Silvestre, J.S.; Castaner, J.; Leeson, P.A.; Sorbera, L.A.; Pagoclone. Drugs Fut 2001, 26, 7, 651.
2 Bourzat, J.-D.; Cotrel, C.; Roussel, G.; Capet, M.; Labaudiniere, R.; Pitchen, P. (Aventis SA); Isoindolinone derivs.. AU 8781911; EP 0274930; FR 2607503; JP 1988154681; US 4960779 .
3 David-Comte, M.-T.; Roussel, G. (Aventis Pharma SA); Novel 2-aminonaphthyridine deriv., its preparation and its use. EP 0522969; FR 2678931 .
4 David-Comte, M.-T. (Aventis Pharma SA); Dextrorotatory isomer of a deriv. of 2-amino naphthyridine and its preparation. EP 0522971; FR 2678933 .
5 David-Comte, M.-T. (Aventis Pharma SA); Process for the preparation of a dextrorotatory isomer of an isoindolinone deriv.. EP 0522972; FR 2678934 .
6 David-Comte, M.-T. (Aventis Pharma SA); Process for the preparation of the optical isomers of 2-aminonaphthyridine derivs.. EP 0522970; FR 2678932 .
7 Cotrel, C.; Crisan, C.; Jeanmart, C.; Messer, M.N. (Aventis Pharma SA); Heterocyclic compounds. BE 0835325; DE 2550111; FR 2313060; FR 2322600; FR 2322601; FR 2322602; GB 1468497; JP 7670776; JP 7733685; JP 7998790; JP 8040671; JP 8051087; US 4220646 .
8 (Aventis Pharma SA); Novel isoindoline derivs., their preparation and compsns. containing them. FR 2229400 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28994 7-amino[1,8]naphthyridin-2-ol C8H7N3O 详情 详情
(II) 11900 2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride 85-44-9 C8H4O3 详情 详情
(III) 47675 2-(7-hydroxy[1,8]naphthyridin-2-yl)-1H-isoindole-1,3(2H)-dione C16H9N3O3 详情 详情
(IV) 47676 2-(7-chloro[1,8]naphthyridin-2-yl)-1H-isoindole-1,3(2H)-dione C16H8ClN3O2 详情 详情
(V) 11334 2-(7-Chloro[1,8]naphthyridin-2-yl)-3-hydroxy-1-isoindolinone C16H10ClN3O2 详情 详情
(VI) 47677 2-Methyl-5-Hexanone; 5-Methyl-2-hexanone; 5-Methyl-2-oxohexane; iso-Amyl methyl ketone; Isopentyl methyl ketone; Methyl isoamyl ketone 110-12-3 C7H14O 详情 详情
(VII) 47678 2-(7-chloro[1,8]naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone C23H22ClN3O2 详情 详情
(VIII) 47679 (rac)-2-[1-[(7-chloro[1,8]naphthyridin-2-yl)amino]-6-methyl-3-oxoheptyl]benzoic acid C23H24ClN3O3 详情 详情
(IX) 47680 (+)-2-[1-[(7-chloro[1,8]naphthyridin-2-yl)amino]-6-methyl-3-oxoheptyl]benzoic acid C23H24ClN3O3 详情 详情
Extended Information